Rheumatoid Arthritis Clinical Trial
Official title:
Effects of Atorvastatin on Disease Activity and HDL Cholesterol Anti-inflammatory Properties in Patients With Rheumatoid Arthritis
This research evaluates the effects of a cholesterol-lowering medication, atorvastatin, on both arthritis activity and the ability of high-density lipoprotein cholesterol (HDL-C, sometimes referred to as "good cholesterol") to prevent changes in low-density lipoprotein cholesterol (LDL-C, sometimes referred to as "bad cholesterol"), which lead to atherosclerosis, or "hardening of the arteries." We hypothesize that atorvastatin may improve both joint inflammation and the anti-inflammatory properties of HDL cholesterol.
Heart attacks are the leading cause of death in patients with rheumatoid arthritis (RA).
Cardiovascular events occur more frequently than would be expected in patients with RA and
traditional heart risk factors do not explain this increased risk. Further research is
needed to pursue ways of reducing heart disease mortality and improving outcome in patients
with RA.
There is reason to believe that a class of cholesterol-lowering medications called statins,
beneficial in cardiovascular disease prevention, may be able to reduce the irritation of the
joints ("inflammation") associated with RA. Statins have been shown to reduce manifestations
of inflammation in the blood of patients at increased risk for heart disease, and in the
process reduce the risk of heart attack, stroke, and sudden death. Some similarities in the
nature of both RA and heart disease may suggest potential benefits of statin therapy in both
conditions.
In addition to inflammation, another factor which may contribute to coronary heart disease
(CHD) risk in RA patients is dysfunctional high-density lipoprotein cholesterol (HDL-C,
sometimes referred to as "good cholesterol"). Normally, HDL-C acts to counter a type of
damage called "oxidation" within LDL-C which is a critical step in the development and
progression of heart disease. Data from patients with RA and system lupus erythematosus
(SLE) suggests that patients with active rheumatic diseases such as RA and SLE may have
increased amounts of dysfunctional HDL-C, and therefore they may be at increased risk of
heart disease. A blood test developed by Dr. Navab and colleagues at UCLA rapidly assesses
this HDL-C function. This study will investigate both the level of HDL-C antioxidant
function in patients with active RA as well as whether abnormal HDL function can be improved
by statin use in this population. This research also evaluates the effects of atorvastatin
on arthritis activity. We hypothesize that atorvastatin may improve both joint inflammation
and the anti-inflammatory properties of HDL cholesterol.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |